Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome

Kamran Afzal(Jawaharlal Nehru Medical College Hospital), Stanley C. Jordan(Cedars-Sinai Medical Center), Shina Menon(Seattle Children's Hospital), Arvind Bagga(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research)
Pediatric Nephrology
October 15, 2007
10.1007/s00467-007-0617-9
Cited by 79

Related Papers

National Conference to Assess Antibody-Mediated Rejection in Solid Organ Transplantation
|American Journal of Transplantation|2004|457
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216